Research Institute of Biotechnology, Hungkuang University, Taichung 43302, Taiwan.
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Int J Mol Sci. 2021 Feb 4;22(4):1577. doi: 10.3390/ijms22041577.
Nonsteroidal anti-inflammatory drugs (NSAIDs) belong to a class of universally and commonly used anti-inflammatory analgesics worldwide. A diversity of drawbacks of NSAIDs have been reported including cellular oxidative stress, which in turn triggers the accumulation of unfolded proteins, enhancing endoplasmic reticulum stress, and finally resulting in renal cell damage. (CC) has been used as a traditional medicine for improving renal function via its anti-inflammatory effects. N-(2-hydroxyethyl)adenosine (HEA), a physiologically active compound, has been reported from CC mycelia (CCM) with anti-inflammatory effects. We hypothesize that HEA could protect human proximal tubular cells (HK-2) from NSAID-mediated effects on differential gene expression at the mRNA and protein levels. To verify this, we first isolated HEA from CCM using Sephadex LH-20 column chromatography. The MTT assay revealed HEA to be nontoxic up to 100 µM toward HK-2 cells. The HK-2 cells were pretreated with HEA (10-20 µM) and then insulted with the NSAIDs diclofenac (DCF, 200 µM) and meloxicam (MXC, 400 µM) for 24 h. HEA (20 µM) effectively prevented ER stress by attenuating ROS production ( < 0.001) and gene expression of ATF-6, PERK, IRE1α, CDCFHOP, IL1β, and NFκB within 24 h. Moreover, HEA reversed the increase of GRP78 and CHOP protein expression levels induced by DCF and MXC, and restored the ER homeostasis. These results demonstrated that HEA treatments effectively protect against DCF- and MXC-induced ER stress damage in human proximal tubular cells through regulation of the GRP78/ATF6/PERK/IRE1α/CHOP pathway.
非甾体抗炎药 (NSAIDs) 属于一类在全球范围内普遍使用的抗炎镇痛药。已报道 NSAIDs 存在多种缺点,包括细胞氧化应激,这反过来又会触发未折叠蛋白的积累,增强内质网应激,最终导致肾细胞损伤。(CC)已被用作通过其抗炎作用改善肾功能的传统药物。N-(2-羟乙基)腺苷 (HEA),一种具有生理活性的化合物,已从 CC 菌丝体 (CCM) 中被报道具有抗炎作用。我们假设 HEA 可以保护人近端肾小管细胞 (HK-2) 免受 NSAID 对 mRNA 和蛋白质水平差异基因表达的影响。为了验证这一点,我们首先使用 Sephadex LH-20 柱层析从 CCM 中分离出 HEA。MTT 测定表明,HEA 对 HK-2 细胞的毒性在 100 µM 以下。HK-2 细胞先用 HEA(10-20 µM)预处理,然后用 NSAIDs 双氯芬酸 (DCF,200 µM) 和美洛昔康 (MXC,400 µM) 处理 24 h。HEA(20 µM)在 24 小时内通过减轻 ROS 产生(<0.001)和 ATF-6、PERK、IRE1α、CDCFHOP、IL1β 和 NFκB 的基因表达,有效预防 ER 应激。此外,HEA 逆转了 DCF 和 MXC 诱导的 GRP78 和 CHOP 蛋白表达水平的增加,并恢复了 ER 稳态。这些结果表明,HEA 治疗通过调节 GRP78/ATF6/PERK/IRE1α/CHOP 通路,有效保护人近端肾小管细胞免受 DCF 和 MXC 诱导的 ER 应激损伤。